Literature DB >> 7673396

Genetic susceptibility for insulin-dependent diabetes mellitus in Caucasians revisited: the importance of diabetes registries in disclosing interactions between HLA-DQ- and insulin gene-linked risk. Belgian Diabetes Registry.

B van der Auwera1, F Schuit, I Lyaruu, A Falorni, S Svanholm, C L Vandewalle, F K Gorus.   

Abstract

Whether genetic susceptibility for insulin-dependent diabetes mellitus (IDDM) at the 5' insulin gene polymorphic region (5' INS) interacts with human leukocyte antigen (HLA)-DQ-linked disease risk and whether it is associated with autoantibody formation is presently controversial. Diabetes registries allow more systematic reassessment of these questions. Two hundred and ninety-six Caucasian IDDM patients were recruited by the Belgian Diabetes Registry and sampled at disease onset, together with 195 ethnically matched control subjects. 5'INS genotypes were determined by Southern blotting, HLA-DQ by allele-specific oligotyping, and autoantibodies by validated immunoassays. The 5' INS 1/1 genotype was more prevalent in patients than in controls [relative risk (RR) = 2.3; P < 10(-4)]. Regardless of age at onset, the 5' INS 1/1 genotype occurred less frequently in patients with the high-risk genotype DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 than in patients without it (P < 0.04). The RR associated with this high-risk HLA-DQ genotype (24.9; P < 10(-6)) was not affected by the presence or absence of the 5' INS 1/1 genotype. Combined positivity for the 5' INS 1/1 genotype and for one of three other HLA-DQ genotypes associated with an intermediate risk for IDDM conferred an age-independent RR of 12.1 (P < 10(-4)). In the absence of the 5' INS 1/1 genotype, intermediate-risk HLA-DQ genotypes no longer conferred a significant risk (2.9; not significantly different from 1). In subjects carrying neutral, protective, or infrequent HLA-DQ genotypes, the overall RR for IDDM was significantly lower than 1 (0.2; P < 10(-6)) in the absence of the 5' INS 1/1 genotype but not in its presence (0.8; not significantly different from 1). The 5' INS 1/1 genotype was not preferentially associated with immune markers for IDDM. In conclusion, regardless of age at onset and the presence of autoantibodies, 5' INS polymorphisms contribute preferentially to IDDM susceptibility in subjects without the highest HLA-DQ-associated risk.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7673396     DOI: 10.1210/jcem.80.9.7673396

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patients.

Authors:  Milca Asanghanwa; Frans K Gorus; Ilse Weets; Bart V der Auwera; Folefac Aminkeng; Eric Mbunwe; Patrick Goubert; Katrijn Verhaeghen; Eugene Sobngwi; Janet M Wenzlau; John C Hutton; Daniel G Pipeleers; Bart Keymeulen; Jean-Claude N Mbanya; Chris van Schravendijk
Journal:  Diabetes Res Clin Pract       Date:  2013-11-20       Impact factor: 5.602

2.  Proinsulin levels and the proinsulin:c-peptide ratio complement autoantibody measurement for predicting type 1 diabetes.

Authors:  I Truyen; P De Pauw; P N Jørgensen; C Van Schravendijk; O Ubani; K Decochez; E Vandemeulebroucke; I Weets; R Mao; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2005-10-07       Impact factor: 10.122

3.  The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity.

Authors:  Robert Hermann; A P Laine; R Veijola; T Vahlberg; S Simell; J Lähde; O Simell; M Knip; J Ilonen
Journal:  Diabetologia       Date:  2005-07-16       Impact factor: 10.122

4.  Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.

Authors:  K Decochez; I Truyen; B van der Auwera; I Weets; E Vandemeulebroucke; I H de Leeuw; B Keymeulen; C Mathieu; R Rottiers; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2005-03-09       Impact factor: 10.122

5.  Seasonality in clinical onset of type 1 diabetes in belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to female excess in incidence.

Authors:  I Weets; L Kaufman; B Van der Auwera; L Crenier; R P A Rooman; C De Block; K Casteels; E Weber; M Coeckelberghs; Z Laron; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

6.  Variable number of tandem repeats of the insulin gene determines susceptibility to latent autoimmune diabetes in adults.

Authors:  Gloria Edith Cerrone; Mariela Caputo; Ariel Pablo Lopez; Claudio González; Carmen Massa; Norberto Cédola; Héctor Manuel Targovnik; Gustavo Daniel Frechtel
Journal:  Mol Diagn       Date:  2004

7.  Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients.

Authors:  E Vandemeulebroucke; B Keymeulen; K Decochez; I Weets; C De Block; F Féry; U Van de Velde; I Vermeulen; P De Pauw; C Mathieu; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2009-11-07       Impact factor: 10.122

8.  Identification of prediabetes in first-degree relatives at intermediate risk of type I diabetes.

Authors:  I Truyen; J De Grijse; I Weets; L Kaufman; L Pipeleers; N Nanos; K Decochez; R Hilbrands; J-M Kaufman; B Keymeulen; C Mathieu; L Van Gaal; D G Pipeleers; F K Gorus
Journal:  Clin Exp Immunol       Date:  2007-05-22       Impact factor: 4.330

9.  HLA-A*24 is an independent predictor of 5-year progression to diabetes in autoantibody-positive first-degree relatives of type 1 diabetic patients.

Authors:  Eric Mbunwe; Bart J Van der Auwera; Ilse Vermeulen; Simke Demeester; Annelien Van Dalem; Eric V Balti; Sara Van Aken; Luc Derdelinckx; Harry Dorchy; Jean De Schepper; Chris van Schravendijk; Janet M Wenzlau; John C Hutton; Daniël Pipeleers; Ilse Weets; Frans K Gorus
Journal:  Diabetes       Date:  2012-11-16       Impact factor: 9.461

10.  Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age.

Authors:  Ilse Vermeulen; Ilse Weets; Milca Asanghanwa; Johannes Ruige; Luc Van Gaal; Chantal Mathieu; Bart Keymeulen; Vito Lampasona; Janet M Wenzlau; John C Hutton; Daniel G Pipeleers; Frans K Gorus
Journal:  Diabetes Care       Date:  2011-06-29       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.